Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-06-14
2011-06-14
Thomas, Timothy P (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S236000, C544S281000, C544S400000, C546S121000, C546S156000, C546S205000, C546S340000, C548S171000, C548S236000, C548S253000, C548S304400, C548S537000, C549S023000, C549S057000, C549S076000, C549S467000, C549S496000
Reexamination Certificate
active
07960369
ABSTRACT:
The GPR40 receptor function regulator of the present invention, which comprises a compound having an aromatic ring and a group capable of releasing cation is useful as an insulin secretagogue or an agent for the prophylaxis or treatment of diabetes and the like.
REFERENCES:
patent: 6294580 (2001-09-01), Wilson et al.
patent: 6555577 (2003-04-01), Mogensen et al.
patent: 6710063 (2004-03-01), Chao et al.
patent: 6723740 (2004-04-01), Chao et al.
patent: 6867218 (2005-03-01), Mogensen et al.
patent: 6867320 (2005-03-01), Shoda et al.
patent: 2004/0058965 (2004-03-01), Momose et al.
patent: 2004/0137517 (2004-07-01), Andrews et al.
patent: 2004/0157890 (2004-08-01), Beswick et al.
patent: 2005/0089866 (2005-04-01), Hinuma et al.
patent: 1 431 267 (2004-06-01), None
patent: WO 97/31907 (1997-09-01), None
patent: WO 99/11255 (1999-03-01), None
patent: WO 00/64876 (2000-11-01), None
patent: WO 01/00603 (2001-01-01), None
patent: WO-01/47859 (2001-07-01), None
patent: WO 01/55085 (2001-08-01), None
patent: WO-01/66098 (2001-09-01), None
patent: WO 02/053547 (2002-07-01), None
patent: WO 02/057783 (2002-07-01), None
patent: WO 02053547 (2002-07-01), None
patent: WO 02/083616 (2002-10-01), None
patent: WO 02/092590 (2002-11-01), None
patent: WO 03/016254 (2003-02-01), None
patent: WO 03/068959 (2003-08-01), None
patent: WO 03/070686 (2003-08-01), None
patent: WO 03/099793 (2003-12-01), None
patent: WO-2004/019869 (2004-03-01), None
patent: WO-2005/009104 (2005-02-01), None
Patini et al., (Bioisosterism: A rational Approach in Drug Design, Chem. Rev. 1998, vol. 96, Issue 8, pp. 3147-3176).
Supplementary European Search Report dated Jan. 22, 2010, from corresponding European Patent Application No. 03810621.7.
Fukatsu Kohji
Harada Masataka
Hinuma Shuji
Ito Yasuaki
Sasaki Shinobu
Conlin David G.
Cornet Jean
Edwards Angell Palmer & & Dodge LLP
Russett Mark D.
Takeda Pharmaceutical Company Limited
LandOfFree
Receptor function regulator does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Receptor function regulator, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Receptor function regulator will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2710077